Panel

panel cytochrome P450 (CYP2D6, CYP2C9, CYP2C19) (pharmacogenetics)

Turnaround time
1.5 week
Performing laboratory
Radboudumc
€ 649

panel cytochrome P450 (CYP2D6, CYP2C9, CYP2C19) (pharmacogenetics)



€ 649

panel cytochrome P450 (CYP2D6, CYP2C9, CYP2C19) (pharmacogenetics)

This test is available for the following conditions:

  • Conditions > Pharmacogenetics > Cytochrome p450 genes (pharmacogenetics)

Turnaround time
1.5 week

Method

  • Targeted analysis of one or more mutations
Remarks
Genetic analysis of the CYP2D6 (CYP2D6*3, CYP2D6*4, CYP2D6*6, CYP2D6*41 and CYP2D6 gene deletion (*5)/gene duplication (xN)), CYP2C9 (CYP2C9*2 and CYP2C9*3) and CYP2C19 (CYP2C19*2, CYP2C19*3 and CYP2C19*17).

Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA




€ 649
Gene

CYP2C19 - cytochrome P450 2C19 (pharmacogenetics)

Turnaround time
Complete analysis & Targeted analysis: 1.5 week
Performing laboratory
Radboudumc
€ 320

CYP2C19 - cytochrome P450 2C19 (pharmacogenetics)



€ 320

CYP2C19 - cytochrome P450 2C19 (pharmacogenetics)

This test is available for the following conditions:

  • Conditions > Pharmacogenetics > Cytochrome p450 genes (pharmacogenetics)

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 1.5 week

Method

  • Targeted analysis of one or more variants using Taqman genotyping
Remarks
Analysis of CYP2C19*2, CYP2C19*3 and CYP2C19*17. Riskfactors for a decreased metabolism of anticonvulsants and antidepressants.

OMIM: 124020
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 320
Gene

CYP2C9 - cytochrome P450 2C9 (pharmacogenetics)

Turnaround time
Complete analysis & Targeted analysis: 1.5 week
Performing laboratory
Radboudumc
€ 320

CYP2C9 - cytochrome P450 2C9 (pharmacogenetics)



€ 320

CYP2C9 - cytochrome P450 2C9 (pharmacogenetics)

This test is available for the following conditions:

  • Conditions > Pharmacogenetics > Cytochrome p450 genes (pharmacogenetics)

This product is also part of the following panels:

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 1.5 week

Method

  • Targeted analysis of one or more variants using Taqman genotyping
Remarks
Analysis of CYP2C9*2 and CYP2C9*3. Riskfactors for a decreased metabolism of approximately 10% of all medications.

OMIM: 601130
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 320
Gene

CYP2D6 - cytochrome P450 2D6 (pharmacogenetics)

Turnaround time
Complete analysis & Targeted analysis: 1.5 week
Performing laboratory
Radboudumc
€ 522

CYP2D6 - cytochrome P450 2D6 (pharmacogenetics)



€ 522

CYP2D6 - cytochrome P450 2D6 (pharmacogenetics)

This test is available for the following conditions:

  • Conditions > Pharmacogenetics > Cytochrome p450 genes (pharmacogenetics)

This product is also part of the following panels:

Turnaround time
Complete analysis & Targeted analysis: 1.5 week

Method

  • Targeted analysis of one or more variants using Taqman genotyping
Remarks
Analysis of the most common variants in CYP2D6: CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41 and CYP2D6 xn. The gene plays an important role in the metabolism of several medications.

OMIM: 124030
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 522